Delia F. Tifrea - Concepedia

Author

Delia F. Tifrea

University of California, Irvine ORCID

Also Known As

D.F. Tifrea, Delia F Tifrea, Delia F. Tifrea, Delia Tifrea, Joshua M. Obiero, Tifrea, Delia F

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University of California, Irvine Institut de Biologie Physico-Chimique University of Iowa The University of Texas MD Anderson Cancer Center University of California, Irvine Medical Center

About

Delia F. Tifrea is an author at University of California, Irvine specializing in medicine, immunology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	805
2	Natural Sciences	2	2	104
3	Public Health	2	2	55
4	Biochemistry	2	2	104
5	Engineering	1	1	211

Delia F. Tifrea

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels Jason W. Hickman, Delia F. Tifrea, Caroline S. Harwood Proceedings of the National Academy of Sciences	2005	834
A spatially resolved single-cell genomic atlas of the adult human breast Tapsi Kumar, Kevin Nee, Runmin Wei, Nature Cell LineageHuman CellEngineeringCell DivisionSingle-cell Genomic Atlas	2023	211
Rapid bacterial detection and antibiotic susceptibility testing in whole blood using one-step, high throughput blood digital PCR Timothy J. Abram, Hemanth Cherukury, C Y Ou, Lab on a Chip	2019	124
Genome-Wide B Cell, CD4+, and CD8+ T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines Swayam Prakash, Ruchi Srivastava, Pierre‐Grégoire Coulon, The Journal of Immunology	2021	97
Two different <i>Pseudomonas aeruginosa</i> chemosensory signal transduction complexes localize to cell poles and form and remould in stationary phase Zehra Tüzün Güvener, Delia F. Tifrea, Caroline S. Harwood Molecular Microbiology Prokaryotic SystemSignal TransductionMolecular PhysiologyBiochemistryStationary Phase	2006	93
Respiratory Syncytial Virus Synergizes with Th2 Cytokines to Induce Optimal Levels of TARC/CCL17 Martha M. Monick, Linda S. Powers, Ihab Hassan, The Journal of Immunology	2007	67
Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccine Delia F. Tifrea, Guifeng Sun, Sukumar Pal, Vaccine Mucosal VaccinationPathogenesisImmunologyProtective AbilityMicrobiology	2011	54
A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors Chunmei Cheng, Pooja Jain, Ilham Bettahi, Vaccine VaccinationToll-like ReceptorsMucosal VaccinationVaccine DevelopmentVaccine Target	2011	48
Increased Immunoaccessibility of MOMP Epitopes in a Vaccine Formulated with Amphipols May Account for the Very Robust Protection Elicited against a Vaginal Challenge with <i>Chlamydia muridarum</i> Delia F. Tifrea, Sukumar Pal, Jean‐Luc Popot, The Journal of Immunology New VaccineMicrobial PathogensImmunologyImmunodominanceRobust Protection	2014	48
Toll-Like Receptor 2-Dependent Activity of Native Major Outer Membrane Protein Proteosomes of Chlamydia trachomatis Paola Massari, Deana N. Toussi, Delia F. Tifrea, Infection and Immunity Toll-like ReceptorsTlr2 AgonistsMicrobial PathogensChlamydia TrachomatisMedicine	2012	43

Page 1